Structure based on 4dkl |
Ideal structure |
|
| Name: methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate |
| Formula: C25 H32 N2 O6 |
| Weight: 456.531 |
| SMILES: "COC(=O)CCC(=O)N[CH]1CC[C]2(O)[CH]3Cc4ccc(O)c5O[CH]1[C]2(CCN3CC6CC6)c45" |
| Spacial conformation based on PDB
4dkl |
RESIDUE BF0 65
CONECT CBF 4 CBG CBE H1 H2
CONECT CBG 4 CBF CBE H3 H4
CONECT CBE 4 CBF CBG CBD H5
CONECT CBD 4 CBE NAJ H6 H7
CONECT NAJ 3 CBD CAK CAI
CONECT CAK 4 NAJ CAL H9 H10
CONECT CAL 4 CAK CAM H11 H12
CONECT CAM 4 CAL CBC CAN CAR
CONECT CBC 3 CAM CAB CAG
CONECT CAN 4 CAM OAA CAO H13
CONECT OAA 2 CAN CAB
CONECT CAB 3 CBC OAA CAC
CONECT CAC 3 CAB OAD CAE
CONECT OAD 2 CAC H14
CONECT CAE 3 CAC CAF H15
CONECT CAF 3 CAE CAG H16
CONECT CAG 3 CBC CAF CAH
CONECT CAH 4 CAG CAI H17 H18
CONECT CAI 4 NAJ CAH CAR H19
CONECT CAR 4 CAM CAI OAS CAQ
CONECT OAS 2 CAR H20
CONECT CAQ 4 CAR CAP H21 H22
CONECT CAP 4 CAQ CAO H23 H24
CONECT CAO 4 CAN CAP NAT H25
CONECT NAT 3 CAO CAU H26
CONECT CAU 3 NAT OAV CAW
CONECT OAV 1 CAU
CONECT CAW 4 CAU CAX H27 H28
CONECT CAX 4 CAW CAY H29 H30
CONECT CAY 3 CAX OAZ OBA
CONECT OAZ 1 CAY
CONECT OBA 2 CAY CBB
CONECT CBB 4 OBA H31 H32 H33
CONECT H1 1 CBF
CONECT H2 1 CBF
CONECT H3 1 CBG
CONECT H4 1 CBG
CONECT H5 1 CBE
CONECT H6 1 CBD
CONECT H7 1 CBD
CONECT H9 1 CAK
CONECT H10 1 CAK
CONECT H11 1 CAL
CONECT H12 1 CAL
CONECT H13 1 CAN
CONECT H14 1 OAD
CONECT H15 1 CAE
CONECT H16 1 CAF
CONECT H17 1 CAH
CONECT H18 1 CAH
CONECT H19 1 CAI
CONECT H20 1 OAS
CONECT H21 1 CAQ
CONECT H22 1 CAQ
CONECT H23 1 CAP
CONECT H24 1 CAP
CONECT H25 1 CAO
CONECT H26 1 NAT
CONECT H27 1 CAW
CONECT H28 1 CAW
CONECT H29 1 CAX
CONECT H30 1 CAX
CONECT H31 1 CBB
CONECT H32 1 CBB
CONECT H33 1 CBB
END
HET BF0 65
HETSYN BF0 beta-funaltrexamine, bound form
HETNAM BF0 methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-d
HETNAM 2 BF0 ihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate
FORMUL BF0 C25 H32 N2 O6
MONOMER page